
Board Member, Leading Expert
Prof. Vivek Subbiah
Stanford University School of Medicine; Stanford Cancer Institute
North America, United States
Professor Vivek Subbiah is a medical oncologist, translational researcher and precision oncology leader specializing in tumor-agnostic therapies, rare cancers and early-phase drug development. At Stanford, he leads work on drug development and precision oncology, with a focus on phase I trials, targeted therapeutics and biomarker-driven trial designs that connect molecular evidence to patient access.
Clinical Trials
Drug Development
Oncology
Precision Oncology
Rare Cancers
Professor of Medicine (Oncology), Stanford University School of Medicine; Associate Director for Drug Development and Precision Oncology, Stanford Cancer Institute
